<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
	<title>Surgical Product Guide &#187; EndoBarrie(TM)</title>
	<atom:link href="http://blog.surgicalproductguide.com/tag/endobarrietm/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.surgicalproductguide.com</link>
	<description>A comprehensive guide to surgical products for medical professionals </description>
	<lastBuildDate>Wed, 05 Jan 2011 20:37:46 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.3</generator>
		<item>
		<title>GI Dynamics&#8217; EndoBarrier non-surgical type 2 diabetes therapy receives CE mark approval</title>
		<link>http://blog.surgicalproductguide.com/2009/12/24/gi-dynamics-endobarrier-non-surgical-type-2-diabetes-therapy-receives-ce-mark-approval/</link>
		<comments>http://blog.surgicalproductguide.com/2009/12/24/gi-dynamics-endobarrier-non-surgical-type-2-diabetes-therapy-receives-ce-mark-approval/#comments</comments>
		<pubDate>Thu, 24 Dec 2009 06:46:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bariatrics]]></category>
		<category><![CDATA[CE Mark]]></category>
		<category><![CDATA[EndoBarrie(TM)]]></category>
		<category><![CDATA[EndoBarrier Gastrointestinal Liner]]></category>
		<category><![CDATA[GI Dynamics]]></category>
		<category><![CDATA[type 2 diabetes]]></category>
		<guid isPermaLink="false">http://www.surgicalproductguide.com/blog/?p=186</guid>
		<description><![CDATA[GI Dynamics has announced that it has received European CE mark approval for the EndoBarrier(TM) a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking certifies that a product has met EU requirements for marketing in Europe. Clinical trials involving more than 270 patients have demonstrated the significant weight loss and diabetes [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://blog.surgicalproductguide.com/files/2009/12/GI-Dynamics.png"><img class="alignleft size-full wp-image-187" style="margin: 5px" src="http://blog.surgicalproductguide.com/files/2009/12/GI-Dynamics.png" border="0" alt="GI Dynamics" width="200" height="148" /></a>GI Dynamics has announced that it has received European CE mark approval for the EndoBarrier(TM) a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking certifies that a product has met EU requirements for marketing in Europe. Clinical trials involving more than 270 patients have demonstrated the significant weight loss and diabetes improvement achieved with the EndoBarrier Gastrointestinal Liner.</p>
<p>For the full story, <a href="http://www.news-medical.net/news/20091222/GI-Dynamics-EndoBarrier-non-surgical-type-2-diabetes-therapy-receives-European-CE-mark-approval.aspx" target="_blank">Click Here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://blog.surgicalproductguide.com/2009/12/24/gi-dynamics-endobarrier-non-surgical-type-2-diabetes-therapy-receives-ce-mark-approval/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

